Interactive Virtual Presentations: HBV Treatment and Response

[Guest guest]

Interactive Virtual Presentations

HBV Providers’ Choice in Prime Time:

Addressing Issues of Patient Populations, Resistance, Individualized Treatment,

Management, and Efficacy

This series of audience-response enabled Interactive Virtual Presentations

provides an overview of HBV treatment and response. When you answer questions

throughout each presentation, a graphic will appear comparing your answers with

those of other participants, along with an audio commentary from the expert

faculty members. To view these Interactive Virtual Presentations, select a link

below.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Heiner Wedemeyer, MD, reviews HBV management in the setting of pregnancy and

potential pregnancy. Topics include:

Rates and Prevention of Mother-to-Child HBV Transmission

Safety of Maternal HBV Treatment During Pregnancy

Adverse Events Associated With Discontinuing HBV Treatment During Pregnancy

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Efficacy, Resistance, and Durability

Locarnini, MD, PhD, FRC (Path), discusses current concepts on how to

best avoid antiviral resistance to initial HBV therapies. Topics include:

Guidelines for Identifying Drug-Resistant HBV

Consequences and Prevention of Drug-Resistant HBV

Role of de Novo HBV Combination Therapy

HBV Cross-Resistance and Multidrug Resistance

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Management of Suboptimal Response

Ching-Lung Lai, MD, reviews strategies to identify and manage incomplete

response in HBV-infected patients receiving treatment with oral antiviral

therapies. Topics include:

HBV Monitoring Recommendations

HBV On-Treatment Roadmap Concept

Predictors of HBV Treatment Response

AASLD Guidelines for the Management of Antiviral-Resistant HBV

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

These Interactive Virtual Presentations are located online at:

http://clinicaloptions.com/Hepatitis/Treatment%20Updates/HBV%20Prime%20Time.aspx

Physicians:

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

Nurses:

Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Release date: December 12, 2008

Expiration date: December 11, 2009

Efficacy, Resistance, and Durability

Release date: December 11, 2008

Expiration date: December 10, 2009

Management of Suboptimal Response

Release date: December 10, 2008

Expiration date: December 9, 2009

Supported by an unrestricted educational grant from Bristol-Myers Squibb.

CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

Not a member yet? Click here | Unsubscribe from all emails sent from CCO |

Manage email preferences

[Guest guest]

Interactive Virtual Presentations

HBV Providers’ Choice in Prime Time:

Addressing Issues of Patient Populations, Resistance, Individualized Treatment,

Management, and Efficacy

This series of audience-response enabled Interactive Virtual Presentations

provides an overview of HBV treatment and response. When you answer questions

throughout each presentation, a graphic will appear comparing your answers with

those of other participants, along with an audio commentary from the expert

faculty members. To view these Interactive Virtual Presentations, select a link

below.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Heiner Wedemeyer, MD, reviews HBV management in the setting of pregnancy and

potential pregnancy. Topics include:

Rates and Prevention of Mother-to-Child HBV Transmission

Safety of Maternal HBV Treatment During Pregnancy

Adverse Events Associated With Discontinuing HBV Treatment During Pregnancy

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Efficacy, Resistance, and Durability

Locarnini, MD, PhD, FRC (Path), discusses current concepts on how to

best avoid antiviral resistance to initial HBV therapies. Topics include:

Guidelines for Identifying Drug-Resistant HBV

Consequences and Prevention of Drug-Resistant HBV

Role of de Novo HBV Combination Therapy

HBV Cross-Resistance and Multidrug Resistance

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Management of Suboptimal Response

Ching-Lung Lai, MD, reviews strategies to identify and manage incomplete

response in HBV-infected patients receiving treatment with oral antiviral

therapies. Topics include:

HBV Monitoring Recommendations

HBV On-Treatment Roadmap Concept

Predictors of HBV Treatment Response

AASLD Guidelines for the Management of Antiviral-Resistant HBV

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

These Interactive Virtual Presentations are located online at:

http://clinicaloptions.com/Hepatitis/Treatment%20Updates/HBV%20Prime%20Time.aspx

Physicians:

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

Nurses:

Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Release date: December 12, 2008

Expiration date: December 11, 2009

Efficacy, Resistance, and Durability

Release date: December 11, 2008

Expiration date: December 10, 2009

Management of Suboptimal Response

Release date: December 10, 2008

Expiration date: December 9, 2009

Supported by an unrestricted educational grant from Bristol-Myers Squibb.

CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

Not a member yet? Click here | Unsubscribe from all emails sent from CCO |

Manage email preferences

[Guest guest]

Interactive Virtual Presentations

HBV Providers’ Choice in Prime Time:

Addressing Issues of Patient Populations, Resistance, Individualized Treatment,

Management, and Efficacy

This series of audience-response enabled Interactive Virtual Presentations

provides an overview of HBV treatment and response. When you answer questions

throughout each presentation, a graphic will appear comparing your answers with

those of other participants, along with an audio commentary from the expert

faculty members. To view these Interactive Virtual Presentations, select a link

below.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Heiner Wedemeyer, MD, reviews HBV management in the setting of pregnancy and

potential pregnancy. Topics include:

Rates and Prevention of Mother-to-Child HBV Transmission

Safety of Maternal HBV Treatment During Pregnancy

Adverse Events Associated With Discontinuing HBV Treatment During Pregnancy

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Efficacy, Resistance, and Durability

Locarnini, MD, PhD, FRC (Path), discusses current concepts on how to

best avoid antiviral resistance to initial HBV therapies. Topics include:

Guidelines for Identifying Drug-Resistant HBV

Consequences and Prevention of Drug-Resistant HBV

Role of de Novo HBV Combination Therapy

HBV Cross-Resistance and Multidrug Resistance

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Management of Suboptimal Response

Ching-Lung Lai, MD, reviews strategies to identify and manage incomplete

response in HBV-infected patients receiving treatment with oral antiviral

therapies. Topics include:

HBV Monitoring Recommendations

HBV On-Treatment Roadmap Concept

Predictors of HBV Treatment Response

AASLD Guidelines for the Management of Antiviral-Resistant HBV

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

These Interactive Virtual Presentations are located online at:

http://clinicaloptions.com/Hepatitis/Treatment%20Updates/HBV%20Prime%20Time.aspx

Physicians:

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

Nurses:

Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Release date: December 12, 2008

Expiration date: December 11, 2009

Efficacy, Resistance, and Durability

Release date: December 11, 2008

Expiration date: December 10, 2009

Management of Suboptimal Response

Release date: December 10, 2008

Expiration date: December 9, 2009

Supported by an unrestricted educational grant from Bristol-Myers Squibb.

CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

Not a member yet? Click here | Unsubscribe from all emails sent from CCO |

Manage email preferences

[Guest guest]

Interactive Virtual Presentations

HBV Providers’ Choice in Prime Time:

Addressing Issues of Patient Populations, Resistance, Individualized Treatment,

Management, and Efficacy

This series of audience-response enabled Interactive Virtual Presentations

provides an overview of HBV treatment and response. When you answer questions

throughout each presentation, a graphic will appear comparing your answers with

those of other participants, along with an audio commentary from the expert

faculty members. To view these Interactive Virtual Presentations, select a link

below.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Heiner Wedemeyer, MD, reviews HBV management in the setting of pregnancy and

potential pregnancy. Topics include:

Rates and Prevention of Mother-to-Child HBV Transmission

Safety of Maternal HBV Treatment During Pregnancy

Adverse Events Associated With Discontinuing HBV Treatment During Pregnancy

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Efficacy, Resistance, and Durability

Locarnini, MD, PhD, FRC (Path), discusses current concepts on how to

best avoid antiviral resistance to initial HBV therapies. Topics include:

Guidelines for Identifying Drug-Resistant HBV

Consequences and Prevention of Drug-Resistant HBV

Role of de Novo HBV Combination Therapy

HBV Cross-Resistance and Multidrug Resistance

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

Click to Access

Management of Suboptimal Response

Ching-Lung Lai, MD, reviews strategies to identify and manage incomplete

response in HBV-infected patients receiving treatment with oral antiviral

therapies. Topics include:

HBV Monitoring Recommendations

HBV On-Treatment Roadmap Concept

Predictors of HBV Treatment Response

AASLD Guidelines for the Management of Antiviral-Resistant HBV

To access this Interactive Virtual Presentation, click here.

To download the slideset that accompanies this presentation, click here.

These Interactive Virtual Presentations are located online at:

http://clinicaloptions.com/Hepatitis/Treatment%20Updates/HBV%20Prime%20Time.aspx

Physicians:

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

Nurses:

Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

HBV Patient Populations: Treating Hepatitis B in the Setting of Pregnancy

Release date: December 12, 2008

Expiration date: December 11, 2009

Efficacy, Resistance, and Durability

Release date: December 11, 2008

Expiration date: December 10, 2009

Management of Suboptimal Response

Release date: December 10, 2008

Expiration date: December 9, 2009

Supported by an unrestricted educational grant from Bristol-Myers Squibb.

CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

Not a member yet? Click here | Unsubscribe from all emails sent from CCO |

Manage email preferences